首页 › 基金 › Pivotal bioVenture Partners Investment Advisor LLC › AVLN

Pivotal bioVenture Partners Investment Advisor LLC 对 AVLN 的持仓历史

AVALYN PHARMACEUTICALS INC · 医疗保健

Pivotal bioVenture Partners Investment Advisor LLC 在 Q3 2026 的 13F 申报中披露持有 AVLN(AVALYN PHARMACEUTICALS INC)866,792 股,市值约 US$24.7M,约占其申报组合的 10.06%,在其申报持仓中市值排名第 4 位。 Pivotal bioVenture Partners Investment Advisor LLC 最近 2 个申报季度中有 2 个季度披露了 AVLN 持仓,最早可追溯至 Q2 2026。

最新持仓 (Q3 2026)866.79K 股
申报持仓市值$24.69M
组合权重10.06%
首次申报Q2 2026
最近变动减持
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Pivotal bioVenture Partners Investment Advisor LLC 对 AVLN 的持仓演变

Pivotal bioVenture Partners Investment Advisor LLC 于 Q2 2026 首次披露 AVLN 持仓:966,792 股(约 US$31.8M)。 在 2 次申报中,Pivotal bioVenture Partners Investment Advisor LLC 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 866,792 股、市值约 US$24.7M,环比减持 -100,000 股。。

逐季持仓明细

季度股数金额变化
Q2 2026 966.79K $31.83M 新进
Q3 2026 866.79K $24.69M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 AVLN 与 13F 数据

AVLN(AVALYN PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 113 只申报持有 AVLN,申报仓位最大的包括:Novo Holdings A/S (US$127.8M), SR ONE CAPITAL MANAGEMENT, LP (US$108.9M), PERCEPTIVE ADVISORS LLC (US$88.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 AVLN 的基金

查看 AVLN 的全部基金持有人 →

常见问题

How long has Pivotal bioVenture Partners Investment Advisor LLC held AVLN?

Pivotal bioVenture Partners Investment Advisor LLC has disclosed AVLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Pivotal bioVenture Partners Investment Advisor LLC's current position in AVLN?

As of Q3 2026, Pivotal bioVenture Partners Investment Advisor LLC holds 866.79K shares of AVLN (AVALYN PHARMACEUTICALS INC), valued at $24.69M, representing 10.06% of its reported portfolio and ranking #4.

Has Pivotal bioVenture Partners Investment Advisor LLC been buying or selling AVLN?

In the latest 13F filing (Q3 2026), Pivotal bioVenture Partners Investment Advisor LLC reduced its position in AVLN.

Which other funds hold AVLN?

Other major institutional holders of AVLN include Novo Holdings A/S, SR ONE CAPITAL MANAGEMENT, LP, PERCEPTIVE ADVISORS LLC, among 113 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.